Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Dumble

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|January 25, 2007
Tumor suppressor dosage regulates stem cell dynamics during agingCatherine Gatza, Lynette Moore, Melissa Dumble, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Insights into aging obtained from p53 mutant mouse modelsMelissa Dumble, Catherine Gatza, Stuart Tyner, et al.
Blood|October 13, 2006
The impact of altered p53 dosage on hematopoietic stem cell dynamics during agingMelissa Dumble, Lynette Moore, Stuart M Chambers, et al.
Molecular Carcinogenesis|May 3, 2006
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null miceBonnie Nannenga, Xiongbin Lu, Melissa Dumble, et al.
The Journal of Pathology|June 16, 2011
Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse modelsTamara Terzian, Melissa Dumble, Farinaz Arbab, et al.
Angiogenesis|April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effectsPuja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Developmental Biology|November 13, 2007
Altered mammary gland development in the p53+/m mouse, a model of accelerated agingCatherine E Gatza, Melissa Dumble, Frances Kittrell, et al.
Molecular Cancer Therapeutics|November 22, 2017
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian CancerAnindya Dey, Xunhao Xiong, Aleia Crim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinasePeter Sabbatini, Jason L Rowand, Arthur Groy, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|January 25, 2007
Tumor suppressor dosage regulates stem cell dynamics during agingCatherine Gatza, Lynette Moore, Melissa Dumble, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Insights into aging obtained from p53 mutant mouse modelsMelissa Dumble, Catherine Gatza, Stuart Tyner, et al.
Blood|October 13, 2006
The impact of altered p53 dosage on hematopoietic stem cell dynamics during agingMelissa Dumble, Lynette Moore, Stuart M Chambers, et al.
Molecular Carcinogenesis|May 3, 2006
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null miceBonnie Nannenga, Xiongbin Lu, Melissa Dumble, et al.
The Journal of Pathology|June 16, 2011
Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse modelsTamara Terzian, Melissa Dumble, Farinaz Arbab, et al.
Angiogenesis|April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effectsPuja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Developmental Biology|November 13, 2007
Altered mammary gland development in the p53+/m mouse, a model of accelerated agingCatherine E Gatza, Melissa Dumble, Frances Kittrell, et al.
Molecular Cancer Therapeutics|November 22, 2017
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian CancerAnindya Dey, Xunhao Xiong, Aleia Crim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinasePeter Sabbatini, Jason L Rowand, Arthur Groy, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Pageof 2